Welding testing apparatus

Product description：W146 hydrate functions as an orthosteric antagonist. It is associated with blood lymphopenia and lung edema in mice.Application：W146 hydrate has been used to assess vascular permeability in mice.

Product description：W146 hydrate functions as an orthosteric antagonist. It is associated with blood lymphopenia and lung edema in mice.Application：W146 hydrate has been used to assess vascular permeability in mice.

Product description：W146 hydrate functions as an orthosteric antagonist. It is associated with blood lymphopenia and lung edema in mice.Application：W146 hydrate has been used to assess vascular permeability in mice.

Product description：W146 hydrate functions as an orthosteric antagonist. It is associated with blood lymphopenia and lung edema in mice.Application：W146 hydrate has been used to assess vascular permeability in mice.

InformationNSC185058 inhibitsATG4B, the lipidation of LC3B, and autophagy without affecting the MTOR or PtdIns3K pathways.

InformationNSC185058 inhibitsATG4B, the lipidation of LC3B, and autophagy without affecting the MTOR or PtdIns3K pathways.NSC185058 is an ATG4B antagonist. ATG4B stimulates autophagy by promoting autophagosome formation through reversible

InformationNSC185058 inhibitsATG4B, the lipidation of LC3B, and autophagy without affecting the MTOR or PtdIns3K pathways.NSC185058 is an ATG4B antagonist. ATG4B stimulates autophagy by promoting autophagosome formation through reversible

InformationNSC185058 inhibitsATG4B, the lipidation of LC3B, and autophagy without affecting the MTOR or PtdIns3K pathways.NSC185058 is an ATG4B antagonist. ATG4B stimulates autophagy by promoting autophagosome formation through reversible

InformationNSC185058 inhibitsATG4B, the lipidation of LC3B, and autophagy without affecting the MTOR or PtdIns3K pathways.NSC185058 is an ATG4B antagonist. ATG4B stimulates autophagy by promoting autophagosome formation through reversible

InformationNSC185058 inhibitsATG4B, the lipidation of LC3B, and autophagy without affecting the MTOR or PtdIns3K pathways.NSC185058 is an ATG4B antagonist. ATG4B stimulates autophagy by promoting autophagosome formation through reversible

InformationNSC185058 inhibitsATG4B, the lipidation of LC3B, and autophagy without affecting the MTOR or PtdIns3K pathways.NSC185058 is an ATG4B antagonist. ATG4B stimulates autophagy by promoting autophagosome formation through reversible

KN-62 is a potent and specific inhibitor of Ca2+/calmodulin-dependent protein kinase II (CaMKII) with Ki of 0.9 μM.A potent and selective inhibitor of CaMKII.